Therapy-Related Myelodysplastic Syndrome Recruiting Phase 2 Trials for Rituximab (DB00073)

DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Recruiting2 IdentifierTitlePurposeDrugs
NCT03096782Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaTreatment
NCT02727803Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple MyelomaTreatment